Skip to content

LABELPHAS

Active Private limited companyfounded 2018active for 7 yearsRue du Nouveau Monde 59, 7060 SoigniesKBO/BCE: BE 0713.923.562
LABELPHAS
Follow ReportCompare

Overview

Lifetime

7 annual accounts with figures on one time axis
peak €63,230 (2024)
€46,198▼ 26.9%
peak €28,095 (2024)
€18,441▼ 34.4%
peak €123,433 (2025)
€123,433▲ 17.6%
€14,050▼ 30.7%
Board2 names since 2018
1 directorSTRENS Alexia
Documentsfilings and deeds
30-04-2026on the last day
2025micro format
Gross margin from €63,230 to €46,198Result from €28,095 to €18,441Equity from €104,992 to €123,433Debts from €20,277 to €14,050

Key points

from the 2025 annual accounts

Equity

€123,433 ▲ 17.6%

LABELPHAS has made a profit in every financial year since 2019.

Liquidity

4.09 was 2.08 in 2024

Short-term debts fell from €20,277 to €12,293.

Filings

7 annual accounts 2 late
deadline202020222024

The 2021 accounts came latest: 18 days after the end of the period.

Checked score

95
Excellent
Financially stronger than 60% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

The dashed line is the sector median: < 0.1% across 24,185 companies (NACE 86, micro).

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 12-2024: 0.1% 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.3%▲ +0.2 percentage points vs 04-2025highest value 06-2025: < 0.1%▼ -0.3 percentage points vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: 0.1%▲ +0.1 percentage points vs 04-2026 06-2026: < 0.1%▼ -0.1 percentage points vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026

Financial strength
Strong

100=equity 89.8% of total assets
79+6short-term debt 8.9% · cash 22.9%
86-11return on assets 13.4%

Score breakdown

lowers risk
Sector: Human health activities (NACE 86)
Liquidity: current ratio 4.09, cash €31,515
Figures for financial year 2025 (filed on 08-05-2026)
Equity €123,433 (89.8% of total assets)
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 60% on liquidity, 36% on profitability and 62% on growth.

The bankruptcy probability was computed on 09-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 30-09-2025.

Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Comparable companies, two years later

In July 2024, 26,972 companies had the same profile as LABELPHAS has now. Each dot stands for 68 companies, two years later.

94.9%
were still trading
3.4%
stopped another way
1.6%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

The bankruptcy probability of LABELPHAS itself is lower: < 0.1% within 12 months. It rests on far more data about LABELPHAS than the profile alone.

Test of the method

The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 26,972 companies, not a prediction for LABELPHAS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit of up to €11,000 on 30-day terms is acceptable

Liquidity is ample, with a current ratio of 4.09 (2.08 in 2024), above the usual 1.5. Short-term debt is 8.9% and cash 22.9% of total assets. 10.2% of the assets are financed with debt and provisions.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

5 signals, none raises the risk
Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 4.09, cash €31,515
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 08-05-2026)
NBB · annual accounts
lowers risk · Equity €123,433 (89.8% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 30-04-2026, 0 days ahead of the deadline.
NBB · 7 filings
Deviation from the deadline
2025
on the day
2024
6 days late
2023
13 days early
2022
18 days early
2021
18 days late
2020
on the day
2019
2 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 1 day before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-09-2026 is due by 30-04-2027. Nothing is late today. The company usually files around 30 April (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
30-09-2026 year end09-11-2026 today30-04-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Board and ownership

SA
STRENS Alexia
Manager
  • STRENS Alexia all the sharesdeed of 23-10-2023
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0713923562
Company renamed from GS BIOMED CONSULTING to LABELPHAS STRENS Alexia holds all the shares · General meeting of 18-10-2023 · Gazette deed
Change of role: STRENS, from manager to director “La prestation de tous types de soins en matière de microbiologie médicale; Toutes activités de coaching…” (deed in French) · General meeting of 24-02-2020 · Gazette deed
Incorporation Founders: STRENS Alexia and GAUTIER Pascal André Serge · Founding capital of €18,600, 100 shares, €6,200 paid up · Appointment: STRENS Alexia (manager) · published on 29-11-2018 · Gazette deed
All 17 events

Comparable companies

same main activity, similar in size and age
Company
LABELPHAS Soignies €137,483 €46,198 89.8% -
Dr NARDELLA Emily Ixelles €147,332 €52,394 81.6% -
CNUDDE ARHUBO MEDICAL Les Bons Villers €60,944 €62,923 49.2% -
DOCTEUR FABIENNE NSANZE Tournai €82,273 €38,286 84.2% -
DR LAURENCE PRATTE PEDIATRIE Ottignies-Louvain-la-Neuve €104,544 €24,429 89.2% -
B’YOU by Dr. Shèdy Maasmechelen €119,852 €112,330 4.5% -
LIPOFINE Brussels €163,435 €124,490 55.7% -

These companies have the same main activity as LABELPHAS: human health activities (NACE 86109). They are comparable in size and age: total assets between €60,900 and €163,000, founded between 2012 and 2021.

Official details

Source: KBO
Status
Active since 27-11-2018Normal situation
Activity
Human health activitiesNACE 86109and 3 others
Establishment unit
2.282.141.9627060 Soignies, since 27-11-2018
Financial year end
30 September
Peppol
Reachable since 21-10-2026
Company details

Annual accounts to 30-09-2025

€46,198▼ 26.9%
≈ €140,000estimated
€18,441▼ 34.4%
€123,433▲ 17.6%
€137,483▲ 9.8%
Filing
Filed on 30-04-2026, on the last day of the filing period
Financials

Insights on LABELPHAS

LABELPHAS files the micro format. That format states no turnover. The gross margin rose from €30,861 in 2019 to €46,198 in 2025.

The balance sheet grew most from 2023 to 2025 through fixed assets.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette.

Financials

Annual accounts 2025

micro format, filed on 30-04-2026, on the day of the deadline
€46,198
▼ 26.9%
€27,884
▼ 35.8%
€45,633
▼ 26.3%
€36,190
▼ 22.2%
89.8%
▲ 6.0 percentage points
4.09
▲ 2.01

Money flows

no detail for 2025

Balance sheet

balance sheet total €137,483 on 30-09-2025
What the company ownsHow it is paid for

in euro

in euro

Position in the sector

Compare with sector

89.8%

Higher than 83% of 20,764 companies in 2025.

4.09

Higher than 63% of 20,339 companies in 2025.

13.4%

Higher than 33% of 20,620 companies in 2025.

LABELPHAS Middle half of the sector 80% of the sector Micro accounts in human health (NACE 86)

Net result: bottom quarter · Equity: middle half · Balance sheet total: middle half · Working capital: middle half

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend2025202420232022202120202019
Balance sheet: assets
20/58 137,483125,269107,82369,32766,84459,54335,594
20 -----134262
21/28 87,22483,13389,28844,84734,79726,47224,830
21 3,870-1,946490---
22/27 83,35483,13387,34244,35734,79724,67223,030
23 --176352529705-
24 24,15821,08528,4985,2555,5412,1202,288
25 --58,66838,750---
26 59,19662,048--28,72721,84720,742
28 -----1,8001,800
29/58 50,25942,13618,53524,48032,04732,93710,503
29 3,750---9,000--
290 ----9,000--
291 3,750------
40/41 14,83515,22110,63616,6852,5358,881426
40 11,33312,2037,50015,833708,792426
41 3,5023,0183,1368522,46589-
50/53 3030727272--
54/58 31,51526,7567,8277,59420,31122,3059,875
490/1 129129-1291291,751202
Balance sheet: equity and liabilities
10/49 137,483125,269107,82369,32766,84459,54335,594
10/15 123,433104,99276,89759,29058,29151,57725,145
10/11 6,2006,2006,2006,2006,2006,2006,200
100 ------18,600
101 ------12,400
13 117,00298,56170,46653,09052,09145,37718,945
133 117,00298,56170,46653,09052,09145,37718,945
14 231231231----
17/49 14,05020,27730,92610,0378,5537,96610,449
17 1,757--2,000---
178/9 1,757--2,000---
42/48 12,29320,27730,9268,0378,5537,96610,449
44 2,194-19,9736,8285,685778998
440/4 2,194-19,9736,8285,685778998
45 6,49417,5658,2202372,8687,1899,451
450/3 6,49417,5658,2202372,8687,1899,451
47/48 3,6052,7122,733972---
Income statement
70 --105,211----
9900 46,19863,23045,01010,76317,63140,47030,861
60/61 --60,201----
630 17,74918,45013,4007,8535,5995,3014,350
640/8 5651,3496601,05050565
9901 27,88443,43131,6042,85010,98235,11925,945
75/76B --1259--0
75 --1259--0
65/66B 5387535521,8791,4001,499715
65 5387535521,8791,4001,499715
9903 27,34642,67831,0531,2309,58233,62025,230
67/77 8,90514,58313,4462312,8687,1896,285
9904 18,44128,09517,6079996,71426,43218,945
9905 18,44128,09517,6079996,71426,43218,945
Appropriation of the result
9906 18,67228,32617,6079996,71426,43218,945
14P 231231-----
691/2 18,44128,09517,3769996,71426,43218,945
6921 18,44128,09517,3769996,71426,43218,945
Document PDFPDFPDFPDFPDFPDFPDF

The notes to these accounts have 8 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the filed accounts (PDF).

Source: Annual accounts 2025 (PDF), filed on 30-04-2026.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank
Financial year Type Filed Reference Document
30-09-2025 micro format 30-04-2026 2026-00105768 PDF
30-09-2024 micro format 06-05-2025 2025-00093447 PDF
30-09-2023 micro format 17-04-2024 2024-00067055 PDF
30-09-2022 micro format 12-04-2023 2023-00058856 PDF
30-09-2021 micro format 18-05-2022 2022-20033598 PDF
30-09-2020 micro format 30-04-2021 2021-13400057 PDF
30-09-2019 micro format 28-04-2020 2020-10900404 PDF

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend2025202420232022202120202019
45,63361,88145,00410,70316,58140,42030,296
36,19046,54531,0078,85212,31331,73223,296
21,84012,29557,84112,33815,6905,92627,640
4,75918,929233-12,717-1,99412,429-
37,96621,859-12,39116,44323,49424,97154
--30.0%----
89.8%83.8%71.3%85.5%87.2%86.6%70.6%
4.092.080.603.053.754.131.01
0.110.190.400.170.150.150.42
14.9%26.8%22.9%1.7%11.5%51.2%75.3%
13.4%22.4%16.3%1.4%10.0%44.4%53.2%
84.8282.1881.535.7011.84--
--26 days----
--121 days----

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Investments

fixed assets acquired
Item30-09-202530-09-202430-09-202330-09-202230-09-2021
Tangible fixed assets€17,970€12,295€56,385€11,848€15,690
Intangible fixed assets€3,870-€1,456€490-
€17,749€18,450€13,400€7,853€5,599

Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)

Insights on LABELPHAS

The operating result for 2025 is 36% lower than in 2024 and the lowest since 2022.

Debt's share of the balance-sheet total falls from 16.2% to 10.2%. Equity is higher and debt is lower.

Board & ownership

Board

1 director, no change since 2020
STRENS Alexia
Manager (not named in the articles)
current term since 24-02-2020 term without a fixed end
listed in the 2025 annual accounts, filed on 30-04-2026

Office holders in the KBO →

Mandates through the years

2 names, the dashed line is today
STRENS Alexia
Manager (not named in the articles)
STRENS
Director (not named in the articles)
BoardEarlierend not dated
Mandates as a list
  • STRENS Alexia
    • Manager (not named in the articles), from 22-11-2018 to date
  • STRENS
    • Director (not named in the articles), appointed by deed of 27-02-2020, no longer listed in the 2025 annual accounts

See the board, name and registered office on a given date →

Control

Shareholder
STRENS Alexia
This company
LABELPHAS
Equity €123,433
Profit €18,441 in 2025

Capital

Contribution
€6,200
Source
2025 annual accounts

Articles of association

Board ruleThese rules set how the board is made up, meets and takes decisions.
“12 ancien (15 nouvelle) dernier alinéa ajouté, exécution au nom et pour compte de la personne morale”
deed of 27-02-2020 (in French)
Kind of sharesThe articles set which classes of shares exist and what rights each class carries.
“5 APPORTS”
deed of 27-02-2020 (in French)
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Last Friday of March at 18:00
deed of 29-11-2018 (in French)
Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
“Pouvoirs les plus étendus prévus par le Code des sociétés et des associations, 34 (33 ancien) DISSOLUTION-LIQUIDATEURS”
deed of 27-02-2020 (in French)

Shareholders

Stated in the deed deed of 23-10-2023 ↗
  • STRENS Alexia all shares

Network & group

No group

LABELPHAS has no parent and no holdings in its annual accounts. STRENS Alexia is the only director. LABELPHAS shares no director with another company.

Timeline

Timeline

17 events since 2018

Deadline for the 2026 accounts: 30-04-2027

2026
Registered in the Peppol Directory Reachable for e-invoices through 0208:0713923562
Annual accounts 2025 filed PDFmicro format · on the deadline day
2025
Annual accounts 2024 filed PDFmicro format · 6 days late
2024
Highest result from 2019 to 2025 net €28,095 ▲59.6% The operating result of €43,431 and the net result of €28,095 are both a record.
Liquidity more than triples current ratio 2.08 The current ratio rises from 0.60 to 2.08. Short-term debt falls from €30,926 to €20,277.
Equity above €100,000 equity €104,992 ▲36.5% With a profit in every financial year since 2019, equity grows to €104,992.
Annual accounts 2023 filed PDFmicro format · 13 days before the deadline
2023
Company renamed from GS BIOMED CONSULTING to LABELPHASSTRENS Alexia holds all the shares · General meeting of 18-10-20234 points ▸
  • General meeting, 18-10-2023
  • STRENS Alexia holds all the shares
  • Name change, LABELPHAS
  • Amendment of the articles, article 1
  • The deed holds 1 more point.

Open the deed in the Belgian Official Gazette

Annual accounts 2022 filed PDFmicro format · 18 days before the deadline
2022
Weakest financial year net €999 ▼85.1% The net result drops to €999, the lowest from 2019 to 2025. It recovers the following year.
Annual accounts 2021 filed PDFmicro format · 18 days late
2021
Annual accounts 2020 filed PDFmicro format · on the deadline day
2020
Liquidity more than quadruples current ratio 4.13 The current ratio rises from 1.01 to 4.13. Short-term debt falls from €10,449 to €7,966.
Annual accounts 2019 filed PDFmicro format · 2 days before the deadline
Change of role: STRENS, from manager to director“La prestation de tous types de soins en matière de microbiologie médicale; Toutes activités de coaching…” (deed in French) · General meeting of 24-02-20204 points ▸
  • Amendment of the articles, article 15
  • General meeting, 24-02-2020
  • Director resignation, STRENS (manager)
  • Director appointment, STRENS (director (not named in the articles))
  • The deed holds 11 more points.

Open the deed in the Belgian Official Gazette

2018
IncorporationFounders: STRENS Alexia and GAUTIER Pascal André Serge · Founding capital of €18,600, 100 shares, €6,200 paid up · Appointment: STRENS Alexia (manager) · published on 29-11-20185 points ▸
  • Founder, STRENS Alexia
  • Founder, GAUTIER Pascal André Serge
  • Founding capital, €18,600, 100 shares
  • Capital, €18,600, 100 shares
  • Director appointment, STRENS Alexia (manager (not named in the articles))
  • The deed holds 2 more points.

Open the deed in the Belgian Official Gazette

First establishment Rue du Nouveau Monde 59, Soignies

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

On 27 November 2018, LABELPHAS was incorporated.1 In 2023 the company took the name LABELPHAS.2 STRENS Alexia has served as manager since 2020.3 Total assets went from €35,594 in 2019 to €137,483 in 2025.4

  1. 1KBO register
  2. 2Belgian Official Gazette, 23-10-2023
  3. 3National Bank, annual accounts 2025
  4. 4National Bank, annual accounts 2019 and 2025

Company details

Identity

Enterprise number
0713.923.562
VAT number
BE 0713.923.562
Peppol ID
0208:0713923562
Legal form
Private limited company
Status
Active, normal situation
Founded
27-11-2018
Financial year
ends on 30 September
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Last Friday of March at 18:00
deed of 29-11-2018 (in French)
Peppol
Reachable since 21-10-2026Follow this company and you will hear the next morning if it leaves the Peppol register.
Name
LABELPHAS in French
Former name
GS BIOMED CONSULTING until the deed of 23-10-2023
Entity type
Legal entity
Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
“Établi en Région Wallonne”
deed of 27-02-2020 (in French)

Activities

NACEBEL 2025
86109 Human health activities main activity
82300 Organisation of conventions and trade shows
85599 Other education
96999 Other personal services
Codes under NACEBEL 2008
86109 Human health activities main activity
82300 Organisation of conventions and trade shows
85599 Other education
96099 Personal service activities
PurposeThe purpose describes the activities the company may carry out under its articles.
“La prestation de tous types de soins en matière de microbiologie médicale; Toutes activités de coaching professionnel; Toutes activités de…”
5 activities
  1. La prestation de tous types de soins en matière de microbiologie médicale.
  2. Toutes activités de coaching professionnel.
  3. Toutes activités de coaching personnel.
  4. Toutes activités de gestion du stress et de bien-être.
  5. La société a pour objet toutes opérations,généralement quelconques,industrielles,commerciales,financières,mobilières et immobilières,se rapportant directement ou indirectement,à l’achat,la vente,la fabrication,la location,le courtage,l’importation,l’exportation et autres entreprises quelconques de tous articles,matériaux,ou moyens quelconques.
deed of 27-02-2020 (in French)

Registered office and establishments

1 establishment
Establishment Since Unit number
Rue du Nouveau Monde 59 registered office 7060 Soignies 47279 Other retail sale of food 27-11-2018 2.282.141.962

Buildings and parcels at the address

Ground area
315 m²
Buildings
47 m²
Volume, LiDAR
442 m³
Tallest building
11.1 m
Buildings to scale, each on its own parcel
47 m², 11.1 m 47 m², 11.1 m

Location

registered office establishment The establishment unit on the map

Parcels

Cadastral parcelArea Buildings Height / floors
55402D0105/00X000315 m² 1 · 47 m² 11.1 m · 3

Contact

E-mail ast@labelphas.com
Phone +32 67 55 50 38

We would like to set cookies. That happens only with your consent. What we measure